Bone building with bortezomib

par Roodman, G. David
Publié 2008

Deciphering Cancer and Bone Interactions for Therapeutic Benefits

par Roodman, G David
Publié dans JBMR Plus (2019)

Myeloma bone disease: Pathophysiology and management

par Silbermann, Rebecca, Roodman, G. David
Publié dans J Bone Oncol (2013)

Multiple Myeloma and Bone: The Fatal Interaction

par Marino, Silvia, Roodman, G. David
Publié dans Cold Spring Harb Perspect Med (2018)

Paget disease of bone

par Roodman, G. David, Windle, Jolene J.
Publié 2005

Pathobiology of Paget's Disease of Bone

par Galson, Deborah L., Roodman, G. David
Publié 2014

Chemokines in multiple myeloma

par Aggarwal, Rohit, Ghobrial, Irene M., Roodman, G. David
Publié 2006

Mechanisms of multiple myeloma bone disease

par Galson, Deborah L, Silbermann, Rebecca, Roodman, G David
Publié 2012

Role of osteocytes in multiple myeloma bone disease

par Delgado-Calle, Jesus, Bellido, Teresita, Roodman, G. David
Publié dans Curr Opin Support Palliat Care (2014)

Osteoblast suppression in multiple myeloma bone disease

par Adamik, Juraj, Galson, Deborah L, Roodman, G David
Publié dans J Bone Oncol (2018)

Epigenetic‐Based Mechanisms of Osteoblast Suppression in Multiple Myeloma Bone Disease

par Adamik, Juraj, Roodman, G David, Galson, Deborah L
Publié dans JBMR Plus (2019)

Resveratrol triggers the pro-apoptotic endoplasmic reticulum stress response and represses the pro-survival XBP1 signaling in human multiple myeloma cells

par Wang, Feng-Ming, Galson, Deborah L., Roodman, G. David, Ouyang, Hongjiao
Publié 2011

Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype

par Kurihara, Noriyoshi, Reddy, Sakamuri V., Menaa, Cheikh, Anderson, Dirk, Roodman, G. David
Publié 2000

A novel role of IL-17–producing lymphocytes in mediating lytic bone disease in multiple myeloma

par Noonan, Kimberly, Marchionni, Luigi, Anderson, Judy, Pardoll, Drew, Roodman, G. David, Borrello, Ivan
Publié 2010

Expression of XBP1s in bone marrow stromal cells is critical for myeloma cell growth and osteoclast formation

par Xu, Guoshuang, Liu, Kai, Anderson, Judy, Patrene, Kenneth, Lentzsch, Suzanne, Roodman, G. David, Ouyang, Hongjiao
Publié 2012

Antisense inhibition of macrophage inflammatory protein 1-α blocks bone destruction in a model of myeloma bone disease

par Choi, Sun Jin, Oba, Yasuo, Gazitt, Yair, Alsina, Melissa, Cruz, Jose, Anderson, Judith, Roodman, G. David
Publié 2001

Annexin II increases osteoclast formation by stimulating the proliferation of osteoclast precursors in human marrow cultures

par Menaa, Cheikh, Devlin, Rowena D., Reddy, Sakamuri V., Gazitt, Yair, Choi, Sun Jin, Roodman, G. David
Publié 1999

Increased signaling through p62 in the marrow microenvironment increases myeloma cell growth and osteoclast formation

par Hiruma, Yuko, Honjo, Tadashi, Jelinek, Diane F., Windle, Jolene J., Shin, Jaekyoon, Roodman, G. David, Kurihara, Noriyoshi
Publié 2009

Annexin II interactions with the annexin II receptor enhance multiple myeloma cell adhesion and growth in the bone marrow microenvironment

par D'Souza, Sonia, Kurihara, Noriyoshi, Shiozawa, Yusuke, Joseph, Jeena, Taichman, Russell, Galson, Deborah L., Roodman, G. David
Publié 2012

The Science and Practice of Bone Health in Oncology: Managing Bone Loss and Metastasis in Patients With Solid Tumors

par Lipton, Allan, Uzzo, Robert, Amato, Robert J., Ellis, Georgiana K., Hakimian, Behrooz, Roodman, G. David, Smith, Matthew R.
Publié 2009